Use of Fluorescein derivatives for the treatment of diseases responsive to the activation of the cystic fibrosis transmembrane conductance regulator chloride channel

Details for Australian Patent Application No. 2001270806 (hide)

International Classifications

Event Publications

8 September 2005 Application Accepted

Published as AU-B-2001270806

17 November 2005 Corrigenda

Applications Accepted - Name Index Under the name University of Bristol, Application No. 2001270806, Under INID (72) correct the name to read Cai, Zhiwei.

12 January 2006 Standard Patent Sealed

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.